Dr. Kathryn A. Akong, MD, PhD

Dr. Akong practices at Rady Children's Hospital San Diego in San Diego, California, part of Rady Children's Health.

Dr. Akong's NPI, 1912169061, was assigned on June 30, 2008. Dr. Akong graduated from University of North Carolina School of Medicine in 2005. Dr. Akong holds California license A96565.

Dr. Akong's primary practice is Rady Children's Hospital San Diego, at 3020 Childrens Way, San Diego, CA 92123 in San Diego County. The practice phone is (858) 576-1700.

Dr. Akong's primary practice is Rady Children's Hospital San Diego in San Diego, California, part of Rady Children's Health. Dr. Akong is also affiliated with Hillcrest Medical Center. The medical group on file is Rady Children's Specialists of San Diego. Dmand AI also links Dr. Akong to 2 more group practices and clinics, 1 therapy and rehab clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Akong practices, 5 sites in all. Vendor and product names are available with a free account.

Pediatric pulmonology is Dr. Akong's primary specialty in the NPI Registry, under taxonomy code 2080P0214X. Dr. Akong is board certified in internal medicine by the American Board of Internal Medicine. Dr. Akong is licensed in California.

CMS data shows 26 Medicare services from Dr. Akong across 1 procedure code in 2024, all of them office visits, for 17 Medicare patients. Medicare paid $2,796 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 17 Medicare patients who saw Dr. Akong in 2024. Their average risk score is 2.51, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Akong's median patient age at 13, with 44% women.

In 2024, Dr. Akong wrote 162 Medicare Part D claims for 17 patients. 35% of them were for generic drugs. CMS names the drug for 72 of them, across 4 drugs with 11 or more claims each, at $865,057 in total drug cost. In 2023, CMS named 13 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 91 out of 100 for Dr. Akong for performance year 2024, reported as part of a group. Dr. Akong accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 12 papers to Dr. Akong, published from 2007 to 2024. 2020 was the busiest year, with 2. The most frequent topics are Adenomatous Polyposis Coli Protein, Cystic Fibrosis and Cystic Fibrosis Transmembrane Conductance Regulator. Dr. Akong has published most often in Dev Biol. Dr. Akong's most frequent co-authors are Yaron Fireizen, MD, Julie Ryu, MD and Praveen Akuthota, MD.

CMS Open Payments shows 20 general payments to Dr. Akong from 7 drug and device companies from 2017 to 2025. Travel and lodging make up the largest share, 54% of the total. Vertex Pharmaceuticals Incorporated paid the most, $1,495.

Dr. Akong graduated from University of North Carolina School of Medicine in 2005.

Dr. Akong is in network with 17 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.